CYCURION INC (CYCU)
NASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
$2.52-1.18%
Close 2026-11-04 · 1-day change
NASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
Research Workspace
Put CYCU beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
IT Consulting & Other Services is in recovery. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Revenue grows to $40 million by end 2026: Comparison needs review.
View ThesisManagement screens weak on capital allocation, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 5% on a typical day and fell roughly 96% in its worst 12-month stretch.
View RiskCYCU trades at 1.6 times sales. Its peer median is 1.3 times sales. The company is unprofitable over the past year. Our model puts the next-quarter miss near 50%. The primary revenue pillar is under pressure. The thesis comparison is not yet verified. Peer multiples imply a price about 61% above where it trades. The thesis is on watch. This read is provisional.
Trailing returns as of 2026-11-04. CYCU is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 1 analyst currently covering CYCU (as of Nov 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare CYCU with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CYCU Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 2 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus IT Consulting & Other Services — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put CYCU next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Grow contracted backlog and revenue to $21-$22 million
Margin expansion and contract support revenue growth objective.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Advances: Regain and maintain Nasdaq listing compliance
Reverse split aids in regaining Nasdaq compliance.
Advances: Grow contracted backlog and revenue to $21-$22 million
Earnings beat and revenue growth support financial objectives.
Advances: Complete acquisition of Secuvant, LLC
Acquisition aligns with growth objectives and expands capabilities.
Advances: Complete acquisition of Secuvant, LLC
Acquisition enhances product offerings and growth potential.